It’s going to take a lot more than the clatter of a kitchen cart to keep Dr. Elizabeth Trehu from presenting the long-awaited results of the PRM-151 and Ruxolitinib clinical trial for myelofibrosis patients. In this impromptu interview conducted in a hotel corridor at ASH, Trehu traces the origin of the project, summarizes the results and talks about plans for the next stage of the PRM-151 trial in her short video, below.
Dr. Elizabeth Trehu, Chief Medical Officer. Promedior
The MD Anderson Report on PRM-151 Results
© 2014, MPNforum, LLC . Unauthorized use and/or duplication of this material without express and written permission is prohibited. Excerpts and links may be used, provided that full and clear credit is given to MPNforum.com with appropriate and specific direction to the original content. All rights reserved under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
MPNforum Magazine 
Comments on: "ASH 2014 SNAPSHOT: Dr. Elizabeth Trehu and PRM-151" (1)
I so hope to be able to try this promising therapy. I have MF with a lot of fibrosis & enlarged spleen. Plan on arranging an appointment with Dr. Mesa at Mayo in Scottsdale.